Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia

CP Lin, YC Tung, FC Hsiao, CH Yang… - The Journal of …, 2020 - Wiley Online Library
Hypertension and dyslipidemia are important risk factors for cardiovascular disease.
However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent …

Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia

CP Lin, YC Tung, FC Hsiao, CH Yang… - Journal of Clinical …, 2020 - hero.epa.gov
Hypertension and dyslipidemia are important risk factors for cardiovascular disease.
However, the clinical outcomes of fixed-dose combination (FDC) versus free-equivalent …

Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia

CP Lin, YC Tung, FC Hsiao… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Hypertension and dyslipidemia are important risk factors for cardiovascular disease.
However, the clinical outcomes of fixed-dose combination (FDC) versus free-equivalent …

[HTML][HTML] Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia

CP Lin, YC Tung, FC Hsiao, CH Yang… - The Journal of …, 2020 - ncbi.nlm.nih.gov
Hypertension and dyslipidemia are important risk factors for cardiovascular disease.
However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent …

Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia.

CP Lin, YC Tung, FC Hsiao, CH Yang… - Journal of Clinical …, 2020 - europepmc.org
Hypertension and dyslipidemia are important risk factors for cardiovascular disease.
However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent …

[PDF][PDF] Fixed-dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia

MS Yi-Wei Kao, MD Yu-Sheng Lin, PH Chu - researchgate.net
Hypertension and dyslipidemia are important risk factors for cardiovascular disease.
However, the clinical outcomes of fixed-dose combination (FDC) versus free-equivalent …